| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |